CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights

EarningsRGX-202RGX-314
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on August 6, 2026 11:05 AM

Read Original